ExThera Medical
Focus: ExThera Medical is a public biotechnology company focused on innovative blood filtration technologies and therapeutics across infectious diseases, cardiovascular, oncology, ophthalmology, and nephrology indications. Founded in 2007 and headquartered in Martinez, CA, the company operates at the intersection of device-based therapies and small molecule pharmaceuticals.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
2+2 this month
Stable — net +2 jobs in 30d
2 added, 0 removed. Backfill posture.
Should You Work at ExThera Medical?
AI assessmentExThera offers a unique opportunity in device-based blood filtration with an approved ophthalmology drug, but limited hiring activity and unconventional pipeline dynamics present execution risk.
Why Work Here
- Commercial validation: OMLONTI (omidenepag isopropyl) is at peak lifecycle with patent protection extending to 2039, providing revenue stability
Data completeness
5/9 — Partial
Company HealthSolid
Pipeline
Early-stage
9 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Help build intelligence for ExThera Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.